跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
plasma derived factor VIII
首页
药物
plasma derived factor VIII
plasma derived factor VIII
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS OF INACTIVATING PATHOGENS USING BROAD-SPECTRUM PULSED LIGHT
EP 1152773 B1
申请人: PUREPULSE TECHNOLOGIES INC
优先权: 1999
CN
EP
WO
3 件公开
METHOD FOR PRODUCING HUMAN PLASMA-DERIVED FACTOR VIII / VON WILLEBRAND FACTOR AND COMPOSITION OBTAINED
EP 4384205 B1
申请人: GRIFOLS WORLDWIDE OPERATIONS LTD
优先权: 2021
EP
US
WO
3 件公开
PROCESS FOR PROTEIN ISOLATION
EP 1765849 A1
申请人: AVT PLASMA LTD
优先权: 2004
EP
WO
2 件公开
Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
US 9663553 B2
申请人: HEMARUS THERAPEUTICS LTD
优先权: 2014
EP
US
2 件公开
Expression system for factor VIII
US 2002102730 A1
申请人: CHO MYUNG-SAM
优先权: 2001
US
2 件公开
Virally-safe factor VIII with a low content of higher multimers
US 7932355 B2
申请人: LFB SA
优先权: 2003
US
2 件公开
Transgenic mammal secreting B-domain deleted human FVII in its milk
US 7667089 B2
申请人: NAT UNIV CHUNG HSING
优先权: 2004
US
2 件公开
Stable factor VIII compositions
US 6599724 B1
申请人: BIOVITRUM AB
优先权: 2000
US
Pharmaceutical preparation for the improved treatment of blood-clotting disorders
EP 1444986 A1
申请人: AVENTIS BEHRING GMBH
优先权: 2003
EP
Pharmaceutical preparation for the treatment of blood-clotting disorders containing factor VIII derived peptides
EP 1454632 A1
申请人: AVENTIS BEHRING GMBH
优先权: 2004
EP
药物
反馈